불임치료 관광 시장 규모, 점유율, 동향 분석 보고서 : 치료별, 연령대별, 국가별, 부문별 예측(2025-2030년)

Fertility Tourism Market Growth & Trends:

The global fertility tourism market size is expected to reach USD 6.18 billion by 2030, exhibiting a CAGR of 25.11% from 2025 to 2030, according to a new report by Grand View Research, Inc. Lower cost of treatment in neighboring countries and a high success rate of IVF in countries such as Spain, U.S., and the U.K. are main factors due to which people are opting for reproductive tourism. Furthermore, the increasing rate of infertility due to factors such as high alcohol consumption, drug abuse, stress, and smoking is propelling the market.

Delayed pregnancy in women is favoring the market growth. Technological advancements and the introduction of IVF and various assisted reproductive technologies are likely to bode well with the market. Countries such as U.S., Spain, India, Czech Republic, are offering advanced treatments such as intracytoplasmic sperm injection, gamete intrafallopian transfer, Zygote intrafallopian transfer, and others. Many single women and gay or lesbian couples have to opt for reproductive tourism as the regulatory frameworks in their home counties do not allow them to avail treatments.

The COVID-19 pandemic adversely impacted the medical tourism industry. It shook the travel and tourism industry to its foundations. Prominent hospital service providers suffered heavy losses in 2020, as COVID-19 pandemic travel restrictions negatively affected medical services aimed at medical tourists. A sharp decline in the number of patient arrivals due to travel bans and strict regulations heavily impacted the fertility tourism industry.

Fertility Tourism Market Report Highlights:

• In terms of age group, the 35-44 segment accounted for the largest revenue share in 2024. The segment is expected to maintain its dominance throughout the forecast period. High infertility rates among this age group and increasing spending capacity are major factors for the dominant share of the segment.
• Turkey dominated the market in terms of revenue share in 2024. Turkey is a popular IVF treatment destination among medical travelers with over 140 IVF clinics.
• Spain is among the most preferred destination for IVF treatment among all the European countries. The country witnessed the influx of patients from France, Italy, the U.S., and other countries owing to quality services and favorable legal framework.
• In July 2020, in line with restrictions caused by the COVID-19 pandemic, Oasis Fertility launched a contactless patient engagement initiative with the goal of expanding the field of fertility tourism through digital media.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
  • 1.4.6. Research Assumption
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Volume Price Analysis
• 1.8. Objectives
  • 1.8.1. Objective - 1
  • 1.8.2. Objective - 2
  • 1.8.3. Objective - 3
• 1.9. List of Secondary Sources
• 1.10. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Fertility tourism market
  • 2.1.1. Market Snapshot
  • 2.1.2. Segment Snapshot
    • 2.1.2.1. Treatment segment outlook
    • 2.1.2.2. Age group segment outlook
    • 2.1.2.3. Country segment outlook
  • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. The rise in accessibility and increasing proximity of healthcare facilities
    • 3.3.1.2. Increase in adoption of digital devices
    • 3.3.1.3. Increasing legal frameworks favoring treatment options
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Strenuous maintenance issues along with increased costs of ART's techniques hinder the market growth
• 3.4. Regulatory Framework
• 3.5. Business Environment Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis

Chapter 4. Treatment Business Analysis

• 4.1. Fertility tourism market: Treatment Movement Analysis
• 4.2. Fertility tourism market: Treatment Segment Dashboard
• 4.3. Treatment Movement & Market Share Analysis, 2024 & 2030
• 4.4. Fertility tourism market Estimates & Forecast, by Treatment
• 4.5. Donor Egg Treatment
  • 4.5.1. Donor egg treatment market, 2018 - 2030 (USD Million)
• 4.6. IVF With Own Egg
  • 4.6.1. IVF with own egg market, 2018 - 2030 (USD Million)
• 4.7. Surrogacy
  • 4.7.1. Surrogacy market, 2018 - 2030 (USD Million)
• 4.8. Donor Embryo
  • 4.8.1. Donor embryo market, 2018 - 2030 (USD Million)
• 4.9. Sperm Donation
  • 4.9.1. Sperm donation market, 2018 - 2030 (USD Million)

Chapter 5. Age Group Business Analysis

• 5.1. Fertility tourism market: Age Group Movement Analysis
• 5.2. Fertility tourism market: Age Group Segment Dashboard
• 5.3. Age Group Movement & Market Share Analysis, 2024 & 2030
• 5.4. Fertility tourism market Estimates & Forecast, by Age Group
• 5.5. 18 - 24
  • 5.5.1. 18 - 24 market, 2018 - 2030 (USD Million)
• 5.6. 25 - 34
  • 5.6.1. 25 - 34 market, 2018 - 2030 (USD Million)
• 5.7. 34 - 44
  • 5.7.1. 34 - 44 market, 2018 - 2030 (USD Million)
• 5.8. 46 - 54
  • 5.8.1. 46 - 54 market, 2018 - 2030 (USD Million)

Chapter 6. Country Business Analysis

• 6.1. Fertility tourism market: Country Movement Analysis
• 6.2. Fertility tourism market: Country Segment Dashboard
• 6.3. Country Movement & Market Share Analysis, 2024 & 2030
• 6.4. Fertility tourism market Estimates & Forecast, by Country
• 6.5. U.S.
  • 6.5.1. U.S. fertility tourism market, 2018 - 2030 (USD Million)
• 6.6. UK
  • 6.6.1. UK fertility tourism market, 2018 - 2030 (USD Million)
• 6.7. Spain
  • 6.7.1. Spain fertility tourism market, 2018 - 2030 (USD Million)
• 6.8. Czech Republic
  • 6.8.1. Czech Republic fertility tourism market, 2018 - 2030 (USD Million)
• 6.9. Portugal
  • 6.9.1. Portugal fertility tourism market, 2018 - 2030 (USD Million)
• 6.10. Thailand
  • 6.10.1. Thailand fertility tourism market, 2018 - 2030 (USD Million)
• 6.11. Malaysia
  • 6.11.1. Malaysia fertility tourism market, 2018 - 2030 (USD Million)
• 6.12. India
  • 6.12.1. India fertility tourism market, 2018 - 2030 (USD Million)
• 6.13. South Korea
  • 6.13.1. South Korea fertility tourism market, 2018 - 2030 (USD Million)
• 6.14. Turkey
  • 6.14.1. Turkey fertility tourism market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Company Market Position Analysis
• 7.3. Company Profiles/Listing
  • 7.3.1. Invacare Corporation
    • 7.3.1.1. Overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Service benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. San Diego Fertility Center
    • 7.3.2.1. Overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Service benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. IVF-Life
    • 7.3.3.1. Overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Service benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Barcelona IVF
    • 7.3.4.1. Overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Service benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Eva Fertility Clinics
    • 7.3.5.1. Overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Service benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. The Surrey Park Clinic
    • 7.3.6.1. Overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Service benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Bumrungrad International Hospital
    • 7.3.7.1. Overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Service benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Assisted ReServiceion and Gynecology Centre
    • 7.3.8.1. Overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Service benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Sincere IVF Center
    • 7.3.9.1. Overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Service benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Alpha IVF & Women's Specialists
    • 7.3.10.1. Overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Service benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Genesis IVF
    • 7.3.11.1. Overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Service benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Manchester Fertility Services Ltd
    • 7.3.12.1. Overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Service benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Apollo Fertility
    • 7.3.13.1. Overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Service benchmarking
    • 7.3.13.4. Strategic initiatives